Fut, nem toboroz1/2. fázis
A phase I clinical trial on combined (neo-)adjuvant intravenous plus intracranial administration of ipilimumab and nivolumab in recurrent glioblastoma.
Key facts
- Where
- Jette, BelgiumSee the site
- Phase
- 1/2. fázis
Where in Belgium
- UZ BrusselJette, BelgiumNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- UZ Brussel
- Trial code
- EU 2023-508278-26-01
- Record updated
- 2025. június 3.